Neurotech Transforms the Delivery of Biologics
Ted Danse, President & CEO for Neurotech, begins by touching upon their ETC technology platform, labeling it as “transformational” in its ability to deliver biologics over multiple years with one simple and minimally invasive procedure. Continuing to detail the key components of their program, Ted expands on the company’s progress thus far.
Edward (Ted) Danse
Mr. Danse was named President and CEO of Neurotech in 2005. He has 30 years of life science industry experience, with over 20 years in the ophthalmic industry.